LEADER 01655nam  2200541Ia 450 
001 9910452160903321
005 20200520144314.0
010   $a1-61209-006-0
035   $a(CKB)2550000001041807
035   $a(EBL)3019049
035   $a(SSID)ssj0000854442
035   $a(PQKBManifestationID)12429203
035   $a(PQKBTitleCode)TC0000854442
035   $a(PQKBWorkID)10902512
035   $a(PQKB)11080887
035   $a(MiAaPQ)EBC3019049
035   $a(Au-PeEL)EBL3019049
035   $a(CaPaEBR)ebr10662855
035   $a(OCoLC)833143440
035   $a(EXLCZ)992550000001041807
100   $a20101012d2011      uy             0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 00$aMultiple sclerosis$b[electronic resource] $ea new paradigm /$feditor, Michel Geffard
210   $aHauppauge, N.Y. $cNova Science$dc2011
215   $a1 online resource (209 p.)
225 0 $aNeurodegenerative diseases--laboratory and clinical research series
300   $aDescription based upon print version of record.
311   $a1-61122-642-2 
320   $aIncludes bibliographical references and index.
410  0$aNeurodegenerative Diseases - Laboratory and Clinical Research
606   $aMultiple sclerosis
606   $aNeurology
608   $aElectronic books.
615  0$aMultiple sclerosis.
615  0$aNeurology.
676   $a616.8/34
701   $aGeffard$b Michel$f1947-$0992737
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910452160903321
996   $aMultiple sclerosis$92273213
997   $aUNINA